Join
Live feed
·
INSIDERFilingvia Quantisnow
ProQR Therapeutics N.V. logo

Director Filius Bart bought $231,000 worth of Ordinary Shares (150,000 units at $1.54) (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
PRQR· ProQR Therapeutics N.V.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PRQR (ProQR Therapeutics N.V.) and more on Quantisnow.